Both Oracle Argus cloud and on-premise deployments have been tested and are fully compliant with the new EV system.
Oracle Argus, a platform that enables biopharmaceutical companies, medical device manufacturers, and contract research organisations to make faster and better safety decisions, optimise global compliance, and easily integrate with the Oracle Health Sciences Empirica platform for signal management, automates and streamlines the entire multi-vigilance lifecycle for drugs, vaccines, and devices from clinical trials through post-marketing surveillance.
The Oracle Cloud offers complete SaaS application suites for ERP, HCM and CX, plus best-in-class database Platform as a Service and Infrastructure as a Service from data centers throughout the Americas, Europe and Asia.
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine
Virbac expands presence in Japan with Sasaeah acquisition
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV